loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Hydralazine Hydrochloride

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Hydralazine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 211Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Macleods Pharmaceutical`s Generics Hydralazine Hydrochloride Receives Approval in US
    Macleods Pharmaceutical`s Generics Hydralazine Hydrochloride Receives Approval in US

    21 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211010

    FDA
    21 Aug 2024
    Share Share
    Enforcement Report - Week of February 21, 2024
    Enforcement Report - Week of February 21, 2024

    21 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2024-40984.pdf

    FDA
    21 Feb 2024
    Share Share
    Enforcement Report - Week of February 14, 2024
    Enforcement Report - Week of February 14, 2024

    14 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf

    FDA
    14 Feb 2024
    Share Share
    I3 Pharms` Generic Isosorbide Dinitrate & Hydralazine Hydrochloride Receives Approval in the U.S.
    I3 Pharms` Generic Isosorbide Dinitrate & Hydralazine Hydrochloride Receives Approval in the U.S.

    17 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215988

    FDA
    17 Jan 2024
    Share Share
    Enforcement Report - Week of October 11, 2023
    Enforcement Report - Week of October 11, 2023

    11 Oct 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-11-2023-46012.pdf

    FDA
    11 Oct 2023
    Share Share
    Upsher-Smith's Generic Hydralazine HCL Receives Receives Approval in the U.S.
    Upsher-Smith's Generic Hydralazine HCL Receives Receives Approval in the U.S.

    10 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083560

    FDA
    10 May 2023
    Share Share